Autonomous Suturing Systems Patent

The European Patent Office published patent application EP4090254A1 for Activ Surgical, Inc. covering systems for autonomous suturing. The invention relates to robotic surgical systems capable of performing suturing operations autonomously, utilizing advanced algorithms and imaging for precision control. The application designates all relevant European member states for potential patent protection.

Intravenous Catheter Assembly with Safety Clip

The European Patent Office published patent application EP4306152A2 for Becton, Dickinson and Company covering an intravenous catheter assembly with a safety clip mechanism. The patent was published March 25, 2026, with inventors including Isaacson, Peterson, McKinnon, and Spataro. The patent designation extends to all EU member states and designated states.

Surgical Gas Delivery Device with Internal Gaseous Sealing Module

The European Patent Office published patent EP4282461A2 granted to CONMED Corporation for a surgical gas delivery device with internal gaseous sealing module and filtered tube set for use in laparoscopic and minimally invasive surgical procedures. The patent covers insufflation technology including gaseous sealing and filtration components. Designated states include all EU member states and extended European states.

Medicament Injector Device

The European Patent Office published Sanofi's European Patent Application EP4289457A2 for a medicament injector device. The patent names four inventors (Soares, Forys, Verlaak, Melzi) and covers IPC classifications A61M 5/20, 5/24, and 5/32 related to injection mechanisms. The application designates all EU and EPC contracting states.

Identification Tag Reader System for Medical Devices

The European Patent Office published patent application EP4275718A2 for Bayer HealthCare LLC covering an identification tag reader system. The invention, filed by inventors Christopher Capone and Jaroslaw Wlodarczyk, is classified under IPC A61M 5/145 and A61M 5/168 relating to medical device infusion systems. The patent designates all EU member states and additional European countries.

Soft Push Tabs for Catheter Adapter

The European Patent Office published patent application EP4233968A2 for Becton, Dickinson and Company's catheter adapter with soft push tabs. The patent application names five inventors including Michael Garrison and Bart Peterson, covering catheter technology in IPC classifications A61M 25/00, A61M 25/06, and A61M 25/02. The application designates all EU member states plus other EPC contracting states.

Pharmaceutical Composition for Prevention or Treatment of Post-Surgical Pain

EPO published patent application EP4084818A2 by Peptinov covering a pharmaceutical composition for preventing or treating post-surgical pain. The composition is classified under IPC codes A61K 38/17, A61K 38/20, and A61P 29/00, with inventors including Azoulai, Cassard, Salles, and Zagury. Designated states cover 31 European countries including major markets.

Pilocarpine Micro-Dose Composition for Treating Presbyopia

The European Patent Office published patent application EP3934643A1 filed by Hyperion DeFi, Inc., covering a pilocarpine micro-dose composition delivered as a stream of droplets for treating presbyopia. The application names inventors Ianchulev and Clauson. The patent is classified under A61K (medicinal preparations), A61P 27/02 (ophthalmologicals), and B05B (atomizing devices).

Treatment of Cancer with LGR5/EGFR Antibody and Topoisomerase I Inhibitor

The European Patent Office published patent application EP4017879A2 by Merus B.V. for a cancer treatment combining an antibody targeting LGR5 and EGFR with a topoisomerase I inhibitor. The invention covers therapeutic compositions and methods for treating cancer, with designated states including major European markets (DE, FR, GB, NL, IT, ES, etc.).

CD3 Binding Molecules Patent for Anticancer Antibodies

The European Patent Office published patent application EP3947456A1 for Merus B.V., covering CD3 binding molecules and anticancer antibodies. The patent was published on March 25, 2026, with inventor Pieter Fokko van Loo. The application covers therapeutic uses related to A61P 35/00 (antineoplastic agents).